Saturday 17 October 2026 Export MIRM’s income statement to Excel — free account

Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $521.3 million, up 54.7% from fiscal 2024. In the quarter to June 2026, revenue grew 37.9%, EPS fell 783.3%, free cash flow fell 681.5% and total debt rose 142.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

80.18 2.21 −2.68%

Follow MIRM

Alert me

Market cap: $5.4B
P/E: 0.0×
Fwd P/E: −6.0×
Dividend yield: —
F-score: 6/9
Altman Z: 4.42
Beneish M: −2.46
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	12.00	9.54	7.61	7.87
P/FCF ratio Full definition →	0.00	0.00	132.73	192.17
P/Operating CF Full definition →	(167.66)	(23.77)	653.56	93.55
P/B ratio Full definition →	0.00	22.42	12.60	12.71
Price to Tangible BV Full definition →	0.00	0.00	73.74	61.72
EV/Sales Full definition →	12.51	9.41	7.47	7.73
EV/EBITDA Full definition →	0.00	0.00	1,011.60	0.00
EV/Operating CF Full definition →	(34.02)	(31.35)	69.71	81.58
EV/FCF Full definition →	(28.24)	(26.47)	130.27	188.74
Quick Ratio Full definition →	2.62	1.90	2.46	3.01
Current Ratio Full definition →	2.86	2.09	2.67	3.31
Net Debt/EBITDA Full definition →	(8.92)	0.10	(37.84)	(7.27)
Debt/Assets Full definition →	71.78%	34.82%	36.76%	39.40%
Debt/Equity Full definition →	(71.97)	1.28	0.98	1.06
Asset Turnover Full definition →	0.70	0.72	0.69	0.65
Operating CF/Net income Full definition →	0.66	0.29	(1.06)	13.66
Capex/Depreciation Full definition →	(3.30)	(1.46)	(0.09)	(0.03)
Interest Coverage Full definition →	(16.25)	(218.33)	(1.27)	0.72
Research and Development Expense of Revenue Full definition →	60.69%	515.51%	34.32%	32.30%
Selling, General and Administrative Expense of Revenue Full definition →	46.23%	60.25%	49.77%	46.55%
Intangible Assets out of Total Assets Full definition →	0.24	0.29	0.31	0.30
Share Based Compensation of Revenue Full definition →	17.35%	22.64%	12.77%	13.63%
Graham Net Nets Full definition →	(0.06)	(0.01)	0.01	0.01
Graham Number Full definition →	7.33	0.00	0.00	0.00
Earnings Yield Full definition →	(12.42%)	(14.72%)	(0.60%)	(1.16%)
Free Cash Flow Yield Full definition →	(3.69%)	(3.73%)	0.75%	0.52%
Revenue per Share Full definition →	2.78	2.72	2.97	2.63
Operating CF per Share Full definition →	(0.70)	(3.89)	0.12	0.78
Capex per Share Full definition →	(0.39)	(0.18)	(0.01)	0.00
Free Cash Flow per Share Full definition →	(1.09)	(4.07)	0.11	0.78
Cash per Share Full definition →	6.92	6.56	7.64	7.42
Shareholders Equity per Share Full definition →	(0.16)	4.12	6.27	5.77
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	(0.16)	4.12	6.27	5.77
Free Cash Flow Full definition →	(69.27)	(239.43)	5.47	39.49
Working Capital Full definition →	413.52	296.61	343.89	370.22
Capital Expenditures Full definition →	(25.02)	(10.66)	(0.60)	(0.19)
Net Current Asset Value Full definition →	(419.09)	(78.99)	21.56	37.51
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.14	0.07	0.00	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	126.10	114.48	100.81	87.83
Average Payables Full definition →	20.54	35.52	12.12	10.86
Average Inventory Full definition →	24.36	23.97	23.65	22.81
Average Assets Full definition →	885.40	790.58	756.78	726.50
Average Common Equity Full definition →	122.37	237.88	270.17	262.04

Show all line items

Columns are period end dates

Stockrow Weekly